SCHEDULE 13D/A: Saba Capital Management Reduces Stake in Nuveen New Jersey Quality Municipal Income Fund
Beneficial Ownership Update
Saba Capital Management, L.P. has filed an Amendment No. 14 to its Schedule 13D, updating its beneficial ownership in Nuveen New Jersey Quality Municipal Income Fund to 11.26% and detailing recent open market share sales.
Summary
- Saba Capital Management, L.P., along with Saba Capital Management GP, LLC and Boaz R. Weinstein (collectively, the "Reporting Persons"), filed an Amendment No. 14 to their Schedule 13D regarding their beneficial ownership in Nuveen New Jersey Quality Municipal Income Fund.
- As of February 10, 2025, the Reporting Persons beneficially own 4,644,785 Common Shares, representing 11.26% of the issuer's outstanding common stock.
- This percentage is calculated based on 41,232,935 shares of common stock outstanding as of August 31, 2024, as disclosed in the company's N-CSR filed on November 8, 2024.
- Since the previous Schedule 13D/A filing on January 15, 2025, the Reporting Persons have engaged in multiple open market sales of Common Shares.
- A total of 414,172 shares were sold between January 15, 2025, and February 10, 2025, at prices ranging from $11.97 to $12.24 per share.
- The funds used for the initial purchase of Common Shares were derived from subscription proceeds from investors, capital appreciation, and margin account borrowings. Approximately $52,672,919 was paid to acquire the Common Shares reported.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the significant selling activity by a major institutional investor, Saba Capital Management, which has reduced its stake in the Nuveen New Jersey Quality Municipal Income Fund. While the filing is purely informational, the divestment by a large holder can be perceived as a lack of confidence or a strategic shift, potentially signaling a negative outlook for the stock.
Positives
- The Reporting Persons have not been involved in any criminal or significant civil proceedings related to securities laws in the last five years.
Negatives
- Saba Capital Management has significantly reduced its stake in Nuveen New Jersey Quality Municipal Income Fund through a series of open market sales, indicating a decrease in their investment or a strategic divestment.
Risks
- The document does not explicitly state risks for the issuer, but the divestment by a significant shareholder like Saba Capital could be perceived as a negative signal by the market, potentially indicating a lack of confidence or a strategic shift by the investor.
Future Outlook
The document does not contain any forward-looking statements or guidance from the issuer or the reporting persons regarding the issuer's future performance or strategic direction. The filing solely updates beneficial ownership and recent transaction activities of the reporting persons.
Industry Context
This Schedule 13D/A filing reflects a significant institutional investor, Saba Capital Management, adjusting its stake in a closed-end municipal income fund. Such filings are common in the investment management industry, particularly for large shareholders who are required to disclose changes in their beneficial ownership. The divestment of shares by a large holder like Saba Capital could be interpreted by the market as a change in investment strategy or outlook regarding the specific fund or the broader municipal bond market, though the filing itself does not provide reasons for the sales.
Comparison to Industry Standards
- NA
Legal Proceedings
- The Reporting Persons (Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein) have not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
- The Reporting Persons have not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws, or finding any violation with respect to such laws, during the last five years.
Stakeholder Impact
- Shareholders: Existing shareholders may view the reduction in stake by a prominent institutional investor like Saba Capital Management as a negative signal, potentially leading to downward pressure on the stock price. New investors might be cautious given the selling activity.
Key Dates
| Date | Description |
|---|---|
| 2015-11-16 | Date of power of attorney for Michael D'Angelo, incorporated by reference to Exhibit 2 of Schedule 13G filed on December 28, 2015. |
| 2015-12-28 | Date of Schedule 13G filing by Reporting Persons, which included the power of attorney. |
| 2024-08-31 | Date as of which 41,232,935 shares of common stock were outstanding for the issuer, as disclosed in the company's N-CSR. |
| 2024-11-08 | Date of the company's N-CSR filing, disclosing shares outstanding as of August 31, 2024. |
| 2025-01-15 | Date of the previous Schedule 13D/A filing and the first reported share sale by Saba Capital. |
| 2025-01-16 | Date of share sale (50,043 shares at $12.06). |
| 2025-01-17 | Date of share sale (45,524 shares at $12.12). |
| 2025-01-21 | Date of share sale (8,300 shares at $12.21). |
| 2025-01-22 | Date of share sale (41,575 shares at $12.17). |
| 2025-01-23 | Date of share sale (11,886 shares at $12.02). |
| 2025-01-24 | Date of share sale (16,681 shares at $12.01). |
| 2025-01-30 | Date of share sale (16,600 shares at $12.11). |
| 2025-01-31 | Date of share sale (16,213 shares at $12.15). |
| 2025-02-03 | Date of share sale (8,836 shares at $12.13). |
| 2025-02-04 | Date of share sale (37,303 shares at $12.14). |
| 2025-02-05 | Date of share sale (41,193 shares at $12.20). |
| 2025-02-06 | Date of share sale (28,936 shares at $12.23). |
| 2025-02-07 | Date of share sale (37,630 shares at $12.21). |
| 2025-02-10 | Date of event requiring filing of this statement and the last reported share sale (36,434 shares at $12.24). |
| 2025-02-11 | Date of filing and signature for the Schedule 13D/A. |
Recommendation
sellKeywords
Saba Capital Management, Nuveen New Jersey Quality Municipal Income Fund, Schedule 13D/A, Beneficial Ownership, Share Sales, Institutional Investor, SEC Filing, Closed-End Fund, Municipal Income Fund, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.